Podcasts about Medicine

Twenty years ago, Hurricane Katrina made landfall in Louisiana, and the levees designed to protect New Orleans failed. Huge swaths of the city flooded, and 1,600 people were trapped inside Charity Hospital. Physician Erica Fisher was working in Charity's emergency room at the time, and she and her colleagues fought for days to keep their patients alive.Host Flora Lichtman speaks with Dr. Fisher, now an emergency medicine physician at University Medical Center in New Orleans, about Hurricane Katrina and the vulnerability of our healthcare systems in the face of disasters.Plus, science writer Maggie Koerth joins Flora to share other science news the week, including the link between heat waves and aging, updated COVID vaccine guidelines, the ancient origins of human mucus, and the possibility that dwarf planet Ceres could once have sustained life.Guest: Dr. Erica Fisher is an emergency medicine physician at University Medical Center in New Orleans, Louisiana.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

Dr. Toni Engram is a biological dentist, integrative health coach, and owner of Flourish Dental Boutique in Richardson, TX. A fter her own personal health struggles with an autoimmune disease, Dr. Engram shifted her practice philosophy to focus on whole-body health, and the prevention and safer treatment of oral disease. She has degrees from Texas Christian University and Baylor College of Dentistry. Dr. Engram is a member of the IAOMT (International Academy of Oral Medicine and Toxicology) and the IABDM (International Academy for Biological Dentistry and Medicine). She is SMART certified in safe amalgam removal technique, accredited through the IAOMT, and is a TBI Ambassador through The Breathe Institute. She is also a certified Integrative Health Coach through the Institute of Integrative Nutrition. In this episode, Dr. Engram talks about the difference in approaches in traditional dentistry vs. biological dentistry, and how to eat and supplement to optimize your oral health!     RESOURCES: Learn more about Dr. Engram here: http://www.flourish.dental/ Instagram: @drtoniengram Get 15% off Peluva minimalist shoe with coupon code COACHTARA here: http://peluva.com/coachtara   CHAPTERS: 0:00 Intro 3:30 How biological dentistry is different 8:30 Fluoride free toothpaste 12:15 Mercury amalgams 18:50 Dr. Engram's personal healing journey 24:00 Link between periodontal and heart diseases 30:35 How to fight decay 36:10 Weston A. Price's dental research in native communities 44:00 Insurance issues   WORK WITH ME: Are You Looking for Help on Your Wellness Journey? Here's how I can help you: TRY COACH TARA APP FOR FREE: http://taragarrison.com/app LEVEL UP PROGRAM: http://taragarrison.com/level-up INDIVIDUAL ONLINE COACHING: https://www.taragarrison.com/work-with-me CHECK OUT HIGHER RETREATS: https://www.taragarrison.com/retreats   SOCIAL MEDIA:  Instagram @coachtaragarrison TikTok @coachtaragarrison Facebook @coachtaragarrison Pinterest @coachtaragarrison   INSIDE OUT HEALTH PODCAST SPECIAL OFFERS: ☑️ Upgraded Formulas Hair Test Kit Special Offer: https://bit.ly/3YdMn4Z ☑️ Upgraded Formulas - Get 15% OFF Everything with Coupon Code INSIDEOUT15: https://upgradedformulas.com/INSIDEOUT15 ☑️ Rep Provisions: Vote for the future of food with your dollar! And enjoy a 15% discount while you're at it with Coupon Code COACHTARA: https://bit.ly/3dD4ZSv   If you loved this episode, please leave a review! Here's how to do it on Apple Podcasts: Go to Inside Out Health Podcast page: https://podcasts.apple.com/us/podcast/inside-out-health-with-coach-tara-garrison/id1468368093 Scroll down to the ‘Ratings & Reviews' section. Tap ‘Write a Review' (you may be prompted to log in with your Apple ID). Thank you!

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: CRISPR modified cell transplant for type 1, risk of T1D if parent has a different type of diabetes, Metformin and the brain, oral GLP-1, and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX A 42-year-old man who has lived most of his life with type 1 diabetes has become the first human to receive a transplant of genetically modified insulin-producing cells. This marks the first pancreatic cell transplant in a human to sidestep the need for immunosuppressant drugs. “This is the most exciting moment of my scientific career,” says cell biologist Per-Ola Carlsson of Uppsala University in Sweden, who helped develop the procedure. The new treatment, he says, “opens the future possibility of treating not only diabetes but other autoimmune diseases.” This procedure uses the gene editing technique, CRISPR, to discourage the auto immune attack on the donor cells. Before the transplant, the participant had no measurable naturally produced insulin and was receiving daily doses of the hormone. But within four to 12 weeks following the transplant, his levels rose slightly on their own after meals—showing that the new beta cells were releasing some insulin in response to glucose. even though the new study is promising, it involved just one participant and is therefore preliminary. And longer-term monitoring is needed to confirm the therapy's safety before it can be offered to more people. She also notes that the injected cells produced only 7 percent of the insulin needed for a person to be fully independent of additional medication. The researchers supplied the recipient with insulin doses to maintain healthy blood sugar levels. While Herold thinks it's still too early to consider this approach for a cure, “these options are now here to change the disease in ways that have never been possible before,” he says. “There's tremendous hope.” https://www.scientificamerican.com/article/type-1-diabetes-patients-insulin-production-restored-with-new-cell/ XX   This one is interesting… a recent study shows that children of mothers with gestational diabetes or fathers with type 2 diabetes have higher chances of developing type 1 diabetes than kids whose parents do not have any type of diabetes. Specifically, the study found that children whose mothers had gestational diabetes during pregnancy were 94% more likely to develop type 1 diabetes compared to children of mothers without diabetes. Similarly, having a father with type 2 diabetes was linked to a 77% higher risk. The study also suggests a possible link between maternal type 2 diabetes and type 1 diabetes in children, although more data are needed to confirm whether the risk is real.   "What is interesting is that type 1 diabetes is a disease of lack of the hormone insulin while gestational diabetes and type 2 diabetes stem mostly from the body's resistance to the hormone. What may be happening is that genes, environments and behaviors that create insulin resistance may also, in some cases, trigger the immune reactions that lead to type 1 diabetes," adds Dr. Dasgupta. A 2019 meta-analysis by researchers at Soochow University in China found that gestational diabetes was linked to a 66% higher risk of type 1 diabetes in children. This new study, which includes more than twice as many studies, offers a robust synthesis of current evidence and shows the risk is even greater than previously estimated. It is also the first meta-analysis to examine the link between paternal type 2 diabetes and type 1 diabetes in offspring. "Several mechanisms may be at play. Families often share lifestyle and eating habits, which can raise the likelihood that children will be affected. But beyond that, high blood sugar levels may also cause biological changes in parents that could increase their children's risk of developing type 1 diabetes," explains Laura Rendon, co-first author of the study, who completed an MSc in experimental medicine at The Institute and, as someone living with type 1 diabetes herself, finds deep personal meaning in conducting this research. For instance, the authors suggest that high blood sugar during pregnancy may stress the fetus's insulin-producing beta cells, reducing their number at birth or making them more vulnerable to damage later in life. It may also trigger epigenetic changes—modifications to proteins and molecules attached to DNA—that increase the risk. Likewise, high blood sugar in fathers with type 2 diabetes may cause epigenetic changes in their sperm, potentially influencing their child's risk of developing type 1 diabetes. https://medicalxpress.com/news/2025-08-diabetes-children-linked-parents.html XX Can a CGM help you lose weight? The company Signos is banking on it – the just got FDA approval for their system, which uses the over the counter Dexcom Stelo. The claim here is that the system will help track how food choices, activity, stress and sleep can all affect metabolism. Signos also works in partnership with the digital nutrition counseling startup Nourish. It currently offers a quarterly subscription plan, including six CGM sensors, for $139 per month. And they tell you don't take any medical actions based on the app's output without consulting a physician. https://www.fiercebiotech.com/medtech/fda-clears-signos-over-counter-cgm-powered-weight-loss-app XX Good news for T1D1, a free mobile app that helps people calculate insulin doses, track daily data, and share insights with healthcare providers. After being pulled off the market with similar apps a few years ago, it's now back and FDA approved. Drew Mendelow created the app after his diagnosis at age 13. He came on the show last year and I'll link his story up in the show notes. Diabetes Center Berne provided the initial funding to support the T1D1 efforts to redesign the app per FDA standards.  Comerge AG , the registered manufacturer, enlisted a team of software engineers, regulatory experts, and design professionals to ensure T1D1 was FDA-ready. Dexcom graciously conducted the Human Factors study to ensure safety and accuracy.  ​ ​T1D1 is now FDA-cleared as a Class II medical device and is the first over-the-counter insulin calculator cleared for individuals aged 2 and older. T1D1 is expected to be live in the AppStore and Google Play Store by October 2025. https://diabetes-connections.com/the-fda-took-down-this-teens-free-bolus-calculator-he-needs-your-help-to-bring-it-back/ XX Metformin has been the standard treatment for type 2 diabetes for more than six decades, yet scientists still do not fully understand how it works. A team from Baylor College of Medicine, working with international collaborators, has now identified an unexpected factor in its effectiveness: the brain. Their findings reveal a brain pathway involved in metformin's glucose-lowering action, pointing to new strategies for treating diabetes with greater precision. The study was published in Science Advances. The researchers concentrated on a small protein called Rap1, located in a region of the brain known as the ventromedial hypothalamus (VMH). They discovered that metformin's ability to lower blood sugar at clinically relevant doses depends on suppressing Rap1 activity in this brain area.   “This discovery changes how we think about metformin,” Fukuda said. “It's not just working in the liver or the gut, it's also acting in the brain. We found that while the liver and intestines need high concentrations of the drug to respond, the brain reacts to much lower levels.”     https://scitechdaily.com/after-60-years-scientists-uncover-hidden-brain-pathway-behind-diabetes-drug-metformin/   XX Looks like GLP-1 pills are moving ahead. Lilly says it's version helped overweight adults with type 2 lose 10% of their body weights and lower A1C. Just two weeks ago, we were talking about how the same drug in people without diabetes had less than the stellar expected results. Orforglipron is a small-molecule pill that is easier to manufacture and package than wildly popular injectable drugs for obesity, such as Lilly's Zepbound and Novo Nordisk's NOVOb.CO rival treatment Wegovy, which are peptide mimics of the appetite-controlling GLP-1 hormone. In the 72-week study of more than 1,600 overweight or obese adults with type 2 diabetes, those who received the 36-milligram highest dose of orforglipron on average shed 10.5% of their weight, or about 23 pounds (10.43 kg), versus 2.2% for those who received a placebo, achieving the main goal of the trial. Patients on the lowest 6 mg dose of the Lilly drug lost 5.5% of their weight. https://www.usatoday.com/story/news/health/2025/08/26/lilly-glp-1-pill-weight-loss/85830686007/ XX     An intervention that combined a low-calorie Mediterranean diet and exercise led to less diabetes incidence in older adults. Men had a greater diabetes risk reduction with the intervention than women. The study was based in Spain, and the diet may not be as easy to adhere to in the U.S. Among nearly 5,000 adults with metabolic syndrome and overweight or obesity in the PREDIMED-Plus trial, those who followed this intervention had a 31% lower risk for type 2 diabetes over 6 years relative to those who received only ad libitum Mediterranean diet advice (aHR 0.69, 95% CI 0.59-0.82). the Mediterranean diet focuses on high intake of plant-based foods, moderate consumption of fish, poultry, and dairy with optional red wine, and low intake of red meats, sweets, and sugar-sweetened beverages. Common foods featured in the diet include extra-virgin olive oil, fruits, vegetables, legumes, nuts, and whole grains. However, Sharon Herring, MD, MPH, and Gina Tripicchio, PhD, MSEd, both of Temple University in Philadelphia, pointed out that this study was conducted solely in Spain, and sticking to this type of diet may be more challenging in countries like the U.S.   "Participants in the study received extra-virgin olive oil to support adherence and retention; in the United States, prices of extra-virgin olive oil have nearly doubled since 2021 due to a combination of factors including climate change, rising production costs, supply chain disruptions, and now tariffs," they noted in an accompanying editorial. "[T]he large number of dietitian contacts during the study may prove difficult to scale broadly in the United States given challenges with health care access and reimbursement for prevention services."         https://www.medpagetoday.com/primarycare/diabetes/117151 XX A group of Canadian researchers has identified an unexpected way to lower blood sugar and protect the liver: by capturing a little-known fuel produced by gut bacteria before it enters the body and causes harm. The findings, published in Cell Metabolism, could open the door to new therapies to treat metabolic diseases like type 2 diabetes and fatty liver disease. Scientists from McMaster University, Université Laval, and the University of Ottawa discovered that a molecule generated by gut microbes can cross into the bloodstream, where it drives the liver to overproduce glucose and fat. By designing a method to trap this molecule in the gut before it reaches circulation, they achieved striking improvements in blood sugar regulation and fatty liver disease in obese mice. https://scitechdaily.com/scientists-discover-a-surprising-new-way-to-fight-diabetes/ XX Dexcom, which specializes in technology for glucose biosensing, will lay off 350 workers, with nearly 200 of them in San Diego, according to the San Diego Union Tribune. The bulk of the local jobs being lost are focused on Dexcom operations and manufacturing. The Dexcom development follows cutbacks to Verily, a life sciences company that is a subsidiary of Alphabet, Google's corporate parent. Verily's work included a project with Dexcom on wearable glucose sensors. CEO Stephen Gillett, in a memo obtained by the publication, said there will be “workforce reductions across Verily.” A representative for Verily confirmed to Business Insider that “we have made the difficult decision to discontinue manufacturing medical devices and will no longer be supporting them going forward.” https://timesofsandiego.com/business/2025/08/27/report-life-sciences-firm-dexcom-lay-off-200-san-diego-workers/ XX Front office changes at Insulet. Eric Benjamin, former chief product and customer experience officer, will take the role of chief operating officer, effective immediately. Manoj Raghunandanan Mu-NOHJ Rug-a-nun-da-nun to the position of chief growth officer, leading Insulet's new growth organization. The appointments are some of CEO Ashley McEvoy's first changes since she was hired in April. The appointments come after McEvoy outlined four priorities for Insulet on an August earnings call:   enhancing the company's commercial capabilities, building Insulet's brand and direct-to-consumer capabilities, driving growth outside of the U.S. and accelerating the pace of innovation. https://www.medtechdive.com/news/insulet-eric-benjamin-manoj-raghunandanan-appointments/758668/ XX   XX Want to highlight The Children's Diabetes Foundation in Colorado – they held a medal ceremony for patients of the Barbara Davis Center who've lived with Type 1 diabetes for 50 years or more. There were 87 medal recipients in the ceremony including Dana Davis, Executive Director of the Children's Diabetes Foundation and the daughter of the founders of the Barbara Davis Center. Davis shared: "When you got Type1 diabetes in the 70s, they thought you shouldn't have children. They thought you weren't going to live past 30 or 40. It was definitely very different," Davis said.   https://www.cbsnews.com/colorado/news/barbara-davis-center-celebrates-colorado-type-1-diabetes-patients-milestone/

This year is the 50th anniversary of the first transcatheter ASD closure in a human. To celebrate this achievement, this week we air a live interview from PICS 2025 in Chicago (conducted 8/26/25) with living interventional cardiology legend Dr. Terry King speaking about the events surrounding his landmark intervention as the first person to ever perform a transcatheter ASD closure with his partner, surgeon Dr. Noel Mills. In this one on one interview, Dr. King discusses how he came up with this idea with Dr. Mills and how he found a patient in which to proceed. He reviews what 'informed consent' was in 1975 and also how he and Dr. Mills accurately estimated ASD size in an era that preceded 2D echocardiography. Dr. King speaks about the role of family in his life and offers advice to the next generation. Finally, he shares with us what he is up to today and why he does not believe in retirement. Prepare to be excited and inspired by this wonderful figure in our field. 

The psychedelic revolutionWill LSD, Psilocybin, MDMA, and Ketamine treatments live up to the hype?For decades, psychedelics were derided as dangerous recreational drugs; now many claim they have the potential to revolutionise the treatment of mental health. With hundreds of clinical trials now taking place, the psychedelic therapeutic market is predicted to be over ten billion within the decade. It has been widely thought that psychedelics are effective at treating mental health because of the way they change brain chemistry. But studies from King's College London and Johns Hopkins suggest this is an error, arguing that it's the psychedelic experience that aids mental wellbeing, not the physical brain changes.Should we stop focussing on brain chemistry as the solution to mental health? What is it about psychedelic experience that can aid mental well being and will psychedelics live up to their promise and usher in a mental health renaissance? Or is the hype bubble about to burst and should we look elsewhere for the silver bullet to the mental health crisis of our age?Matthew Johnson is Professor of Psychiatry and Behavioural Sciences at Johns Hopkins University. Shayla Love is a freelance reporter and former senior science writer at Vice News, focusing on psychedelics. Kevin Sabet is the founder of Smart Approaches to Marijuana, and he has been described as the "quarterback of the new anti-drug movement".Don't hesitate to email us at podcast@iai.tv with your thoughts or questions on the episode!To witness such debates live buy tickets for our upcoming festival: https://howthelightgetsin.org/festivals/And visit our website for many more articles, videos, and podcasts like this one: https://iai.tv/You can find everything we referenced here: https://linktr.ee/philosophyforourtimesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Nutritionist Leyla Muedin discusses the critical role of mitochondrial health throughout the lifespan, citing Dr. Jeffrey Bland's insights on mitochondria as a cornerstone of 21st-century health. The episode explores the benefits of ketosis and the ketogenic diet, particularly in supporting neurological health and conditions like epilepsy, Alzheimer's, and multiple sclerosis. Leyla highlights how ketogenic diets stimulate mitochondrial biogenesis and improve mitochondrial function while addressing potential contraindications for specific populations. The importance of a functional medicine approach and personalized interventions is emphasized for optimal health outcomes.

Send us a textThe potential link between acetaminophen (Tylenol) and autism, with a surprise phone call from RFK partway through.Episode Summary: Dr. William Parker talks about autism spectrum disorder (ASD), its rising prevalence since the 1980s, and the controversial hypothesis that acetaminophen exposure in susceptible infants and children triggers most cases via oxidative stress. They discuss ASD's clinical definition; historical misconceptions like the "refrigerator mother" theory; genetic susceptibilities; acetaminophen's metabolism, which produces toxic byproducts in underdeveloped livers, leading to brain effects.About the guest: William Parker, PhD spent nearly 30 years as a professor at Duke University researching underlying causes of chronic conditions, including discovering the immune function of the human appendix and pioneering studies on immune systems in wild animals.Discussion Points:Autism is a spectrum disorder with core symptoms like social deficits, repetitive behaviors, and aversion to new stimuli.Parker argues overwhelming evidence points to acetaminophen as the primary trigger in susceptible individuals, causing oxidative stress via toxic metabolite NAPQI.Acetaminophen, marketed as Tylenol or paracetamol, was not tested for neurodevelopmental effects in neonatal animals until 2014, despite widespread use since 1886; it's metabolized differently in babies, whose livers lack mature detox pathways.Susceptibility factors include low glutathione (an antioxidant), poor sulfation/glucuronidation metabolism, folate receptor autoantibodies, and events like immune reactions that prompt acetaminophen use during oxidative stress.Regressive autism, where children lose milestones after seeming normal, often follows acetaminophen given for fevers or illnesses, explaining parental vaccine suspicions (as shots coincide with drug use).Adult acetaminophen is generally safe but causes liver toxicity in overdoses or with alcohol; antidote is NAC to boost glutathione.Parker has suggested to policymakers that we should avoid acetaminophen during pregnancy, birth, and early childhood (under age 3-5); parents should plan ahead for fevers/pain without it, but seek medical help for unusual symptoms.*Not medical advice.Support the showAffiliates: Seed Oil Scout: Find restaurants with seed oil-free options, scan food products to see what they're hiding, with this easy-to-use mobile app. KetoCitra—Ketone body BHB + electrolytes formulated for kidney health. Use code MIND20 for 20% off any subscription (cancel anytime) Lumen device to optimize your metabolism for weight loss or athletic performance. Code MIND for 10% off SiPhox Health—Affordable at-home blood testing. Key health markers, visualized & explained. Code TRIKOMES for a 20% discount. For all the ways you can support my efforts

Garry Nolan, PhD, is an immunologist and professor at Stanford University School of Medicine. He is also a business executive and Executive Director of the Board of the Sol Foundation, a research and advocacy center focused on UAP studies.  www.thesolfoundation.org Hunt with confidence using onX Hunt. Start your free trial today at: https://huntsmarter.smart.link/srwbpznr2 This video is sponsored by BetterHelp. Visit https://BetterHelp.com/JRE Learn more about your ad choices. Visit podcastchoices.com/adchoices

⭐️Mentioned in This Episode:- See all the resources

Right up front here, let me just state loudly that there are some amazing independent TPAs (third-party administrators) out there who have the expertise, the scrappy willfulness, and the deep desire to do right by their clients, their self-insured employer clients. For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. And look, they may be facing some of the same headwinds that plan sponsors themselves face, like anticompetitive contracts, brokers who are up to no good, etc. So, just keep that in mind as you listen. And the main point of all of this if you are a plan sponsor is, find a good TPA partner, which, as Bryce Platt has said about consultants but same rules apply about TPAs here, the difficulty is being informed enough to tell the difference. So, the goal of this show is to help with that, the “be informed enough to tell the difference.” All of this being said, this is technically a Take Two; but we trimmed it down and welcome to a whole new intro. So, call this a refresher and an update about a really, really important topic from last year that is becoming extremely (maybe even more) relevant this year. Really relevant. Consider, for example, the show with Claire Brockbank (EP453) about carrier/TPA RFPs (requests for proposal) and all of the landmines that are really expensive, that are buried in some of these contracts. Then there was the Cynthia Fisher show (EP457) from last year about the millions, maybe billions of dollars in aggregate going missing in medical (ie, TPA or ASO [administrative services only]) spread pricing. We had “The Mystery of the Weekly Claims Wire” show with Justin Leader (EP433), again, revealing money that's being disappeared when the TPA is withdrawing dollars from plan sponsor checking accounts. And then there's the payment integrity episode with Kimberly Carleson (EP480) from a few weeks ago with just another wrinkle on this, namely TPAs or ASOs who insist on auditing themselves and how that turns out for members and plan sponsors. Oh, and last, but certainly not least, is the whistleblower show with Ann Lewandowski (EP476) on how a TPA arm of an EBC (employee benefit consultant) allegedly pocketed $20 million—$20 million of their client's pharma rebates—and used that $20 million to fund their executive bonus pool. What a time to be alive! All of this just highlights the huge stakes for plan sponsors to really understand what their TPA is all about. And when I say high stakes, I mean from both a legal standpoint and also just vast dollars in play here. But this episode with Elizabeth Mitchell is also, I'm gonna say, extremely relevant given just a few ripped from the headlines and news articles such as these. I'm gonna start actually with a post from Kimberly Carleson, and I like the comment by Jeff Evans, who wrote, “How does $8,710 equal $104,266?” Spoiler alert, it doesn't. Lots of missing dollars there. Someone's hands are in the cookie jar. Oh, look, the TPA has entered the chat. In a nutshell, and I'm quoting something Peter Hayes wrote, he wrote, “TPAs have received relatively little public attention. [There's an article in Health Affairs] that describes how TPAs impose hidden fees, benefit from their own form of spread pricing, and otherwise prioritize their own financial interests over those of their plan clients.” Also, here's a totally other issue. Let me quote Luke Prettol highlighting something Jason Shafrin had written about a paper by Jeff Marr, Daniel Polsky, and Mark Meiselbach. Let me slightly rephrase what Luke said. He wrote, “Employers pay, on average, a 4.7% [so almost 5%] price markup when hospitals are in their TPA's [Medicare Advantage] network.” Right? Dr. Eric Bricker talked about this in that episode (EP472) just how TPAs with MA (Medicare Advantage) business negotiate their commercial clients to pay higher rates so that then they can pay lower rates for their own MA members. As Luke wrote, “On its face, this overpayment does not appear to be solely in the interest of participants.” No kidding. Now, let's spin the wheel here. There are barriers for TPAs themselves, even the ones who have a deep desire to do the right thing. As Patrick Moore wrote, “Most TPAs still can't do [many of the things that employers might want because there are] PPO contracts.” So, is it a rock in a hard place situation? I mean, if the TPA has no other options than using a carrier's PPO (preferred provider organization) network with all its attendant contractual issues, then yeah, that is one definite challenge. Along these lines, let me read a post by Rina Tikia, because I think she sums up this really well. “When independent TPAs … push for transparency, they're blocked under the banner of ‘fiduciary risk.' “Meanwhile, the largest carriers and PBMs, with Cayman shell subsidiaries, DOJ kickback probes, [huge] hedge fund ties, [$10 million-plus] lobbying budgets, and antitrust violations continue unchecked. They are not only allowed to operate but celebrated as mainstream options. “Why the double standard? Political donations? Foundation smokescreens? Nonprofit status as a PR shield?” These are excellent questions. And here's another challenge: brokers. Ramesh Kumar Budhani wrote about this one, just how hard it is sometimes to find—for TPA, an independent TPA, trying to do the right thing—to find brokers who prioritize doing the right thing for employers and helping their clients save money. The summary of all of this: There are TPAs and there are ASOs who aren't even trying. They are going to ride the flywheel, the gravy train, and catch all of the dollars flying off of it for as long as they can manage to cling to it with all 10 of their fingers. Then there are TPAs, mostly indies, trying super hard to do the right thing. But how successful they are is going to depend on how boxed in they are by the PPO networks or the carriers that the brokers or even plan sponsors may insist on. Just how courageous they are and just how smart they are and experienced they are about the market and how it actually operates. So, the show that follows is about all of this, including how we can inspire TPAs, which, in the show that follows, subsumes ASOs kind of into it. But in the show that follows, I hope it's inspiring to create an environment so that the market demands TPAs that do all of the things, and we make inertia not a viable business strategy. Elizabeth Mitchell, my guest today, currently serves as the president and CEO of the Purchaser Business Group on Health. Also mentioned in this episode are Purchaser Business Group on Health; Bryce Platt; Claire Brockbank; Cynthia Fisher; Justin Leader; Kimberly Carleson; Ann Lewandowski; Jeff Evans; Peter Hayes; Luke Prettol; Jason Shafrin; Jeff Marr; Daniel Polsky; Mark Meiselbach; Eric Bricker, MD; Tom Nash; Patrick Moore; Rina Tikia; Ramesh Kumar Budhani; Mark Cuban; Harold Miller; Chris Deacon; Moby Parsons, MD; Benjamin Schwartz, MD, MBA; Mishe Health; Rik Renard; and Cora Opsahl. You can learn more at PBGH and by connecting with Elizabeth on LinkedIn.   Elizabeth Mitchell, president and CEO of the Purchaser Business Group on Health (PBGH), advances its strategic focus areas of advanced primary care, functional markets, and purchasing value. She leads PBGH in mobilizing health care purchasers, elevating the role and impact of primary care, and creating functional healthcare markets to support high-quality affordable care, achieving measurable impacts on outcomes and affordability. At PBGH, Elizabeth leverages her extensive experience in working with healthcare purchasers, providers, policymakers, and payers to improve healthcare quality and cost. She previously served as senior vice president for healthcare and community health transformation at Blue Shield of California, during which time she designed Blue Shield's strategy for transforming practice, payment, and community health. Elizabeth served as the president and CEO of the Network for Regional Healthcare Improvement (NRHI), a network of regional quality improvement and measurement organizations. She also served as CEO of Maine's business coalition on health (the Maine Health Management Coalition), worked within an integrated delivery system (MaineHealth), and was elected to the Maine State Legislature, serving as a State Representative. Elizabeth served as vice chairperson of the U.S. Department of Health and Human Services Physician-Focused Payment Model Technical Advisory Committee, board and executive committee member of the National Quality Forum (NQF), member of the National Academy of Medicine's “Vital Signs” Study Committee on core metrics, and a guiding committee member for the Health Care Payment Learning & Action Network. Elizabeth holds a degree in religion from Reed College and studied social policy at the London School of Economics.   08:06 What is the overarching context for health plans in healthcare purchasing? 11:31 Why is it important to reestablish a connection between the people paying for care and people providing care? 13:47 What are the needs of a self-insured employer when managing employee benefits? 19:00 Is it doable for employers to set their own contracts? 21:24 Is transparency presumed? 22:39 Will the new transparency upon us actually expose wasted expense? 24:23 EP408 with Chris Deacon. 25:58 “This is not about individual bad actors. … The systems … that is not aligned.” 27:39 Are there providers who want to work directly with employers? 30:53 Why is it important that incentives need to be aligned? 32:42 EP427 with Rik Renard. 33:51 What's missing from the conversation on changing health plans?   You can learn more at PBGH and by connecting with Elizabeth on LinkedIn.   @lizzymitch2 of @PBGHealth discusses #TPA and #healthplan vs. #jumboemployer inertia on our #healthcarepodcast. #healthcare #podcast #financialhealth #patientoutcomes #primarycare #digitalhealth #healthcareleadership #healthcaretransformation #healthcareinnovation   Recent past interviews: Click a guest's name for their latest RHV episode! Dave Chase, Jonathan Baran (Part 2), Jonathan Baran (Part 1), Jonathan Baran (Bonus Episode), Dr Stan Schwartz (Summer Shorts), Preston Alexander, Dr Tom X Lee (Take Two: EP445), Dr Tom X Lee (Bonus Episode), Dr Benjamin Schwartz, Dr John Lee (Take Two: EP438), Kimberly Carleson, Ann Lewandowski (Summer Shorts)  

Medicine isn't fair, and often it sets us up for burnout in ways we don't even realize. So what do we do when the system is rigged against us? Let's dive in to how we overcome that while also avoiding burnout. Join me for my FREE course: coach-miles.com/secret

How much leucine should I take to regain muscle?Should I increase my creatine dose to 10 grams daily for the cognitive benefits?You talked about the cancer risk of CT scans. What about CT angiograms?  I've had a ganglion cyst drained twice. How can I keep it from coming back?Who can I contact for treatment of mast cell activation syndrome?I heard you should brush your teeth with fluoride toothpaste if there's no fluoride in your drinking water 

How reliable is nutrition science?I have gingivitis, and my dentist recommended Listerine. Won't that disrupt the microbiome in my mouth?I take a diuretic for high blood pressure. Is it okay to stop drinking water by 8pm, or will I dehydrate?Is there a way to get rid of seborrheic keratoses?

The concept of Food as Medicine has been central to Biological Soil Management, drawing a clear connection between human health and turf health. Just as proper nutrition helps our bodies build natural immunity and resist disease, balanced fertility programs help turf recover from stress, develop stronger roots, and support healthy soil biology.In this episode, we revisit one of Jerry's lectures given over a decade ago in Australia, where he discusses the importance of nutrition for long-term health. While his focus here is on human health, he often highlights the parallels to plant health and the role of nutrition in building resilience.At EarthWorks, this philosophy continues to guide our fertility approach, with natural products like Replenish fertilizers and CalVantage designed to build healthy soils and stronger turf.Visit EarthWorks at:  https://www.earthworksturf.com Podcasts: https://www.earthworksturf.com/earthworks-podcasts/ 2 Minute Turf Talks: https://www.earthworksturf.com/2-minute-turf-talks/

In this episode, Kris sits down with Hugh Vail, friend, founder, and lead facilitator of Mustang Medicine, an immersive program designed to help people reconnect with themselves, their emotions, and the natural world. Hugh guides participants through powerful practices that strip away the noise of modern life and bring them back to a place of truth, resilience, and presence. Over a four-day retreat at Holmstead Ranch Resort in Central, Utah, Mustang Medicine offers an experience unlike any other. Participants step into wild horse encounters, sweat lodge ceremonies, breathwork, cold-water therapy, and ceremonial rituals — all woven together to create a journey Hugh calls “ReWilding.” We explore: • The healing power of wild horse encounters • How sweat lodges and ceremonial practices foster emotional release and clarity • Why cold-water immersion and breathwork build resilience • The importance of community and integration in living a conscious life • Hugh's personal mission to guide others back to themselves If you've ever felt the pull to strip away the distractions, reconnect with nature, and find deeper meaning, this conversation will speak to you.  Learn more about Mustang Medicine: https://mustangmedicine.com/ Join the Conversation: Follow us on Instagram, Facebook or message us directly — we read every one. If this episode made a difference, please share it with someone who needs to hear it. And if you haven't yet, drop us a review — it helps more people find this space. #PushingBackChaos #MustangMedicine #ReWilding #EmotionalResilience #ConsciousLiving #Breathwork #ColdWaterTherapy #WildHorseMedicine #HealingJourney #FindYourself #HMG #HeroesMediaGrp  Learn more about your ad choices. Visit megaphone.fm/adchoices

One of the funniest episodes we've had. Really irreverant side commentary. Good clinical discussions for learners. Discussed aggressive resuscitation, treating acidosis, and treating hyperkalemia. Come on a trip with the Wise Guys. 

The Advancement Strategic Communicators Network is a growing national hub for higher education philanthropic communicators. Learn more on the ASC website  (https://asc.ucdavis.edu/)  or join the ASC Linkedin Group (https://www.linkedin.com/groups/12740101/) to get connected.Guest Name: Gabrielle Giddings, Associate Vice Chancellor, Campaigns, University of DenverGuest Social: https://www.linkedin.com/in/gabriellegiddings/Guest Bio: Gabrielle Giddings is the associate vice chancellor of campaigns at the University of Denver, leading campaign communications, advancement events, and campaign operations for the University's $1B Denver Difference campaign. An advancement leader with 30+ years of experience, she believes clear, authentic storytelling builds donor trust and fuels giving. Previously, she served as assistant vice president for marketing and communications at Temple Health Institutional Advancement and the Lewis Katz School of Medicine, directing an integrated program across the health system, the school, and the university. Her expertise spans campaign communications, high-impact events, direct response, donor and alumni engagement, community relations, and crisis/media management. She holds a B.A. in Archaeology from Bryn Mawr College and an M.S. in Communication Management from Temple University (communication theory and cross-cultural leadership). - - - -Connect With Our Host:Mallory Willsea https://www.linkedin.com/in/mallorywillsea/https://twitter.com/mallorywillseaAbout The Enrollify Podcast Network:The Higher Ed Pulse is a part of the Enrollify Podcast Network. If you like this podcast, chances are you'll like other Enrollify shows too!Enrollify is made possible by Element451 — The AI Workforce Platform for Higher Ed. Learn more at element451.com.

Overview: We sit down with Dr. Lonnie Nelson, a clinical psychologist and member of the Cherokee Indians, to explore the importance of centering Native communities in healthcare research and practice. We learn about how Lonnie's personal experiences with family health challenges shaped his professional journey, and how he reframes common clinical approaches to focus on culture, self-determination, and relational trust. We dive deep into the role of "culture as medicine," uncovering how traditional practices and genuine human connection can foster healing far beyond what Western medicine often recognizes. We also discuss Lonnie's work addressing health disparities, brain health research in urban Native elders, and the need to move away from transactional, role-based healthcare toward true person-centered care. Three Takeaways: - Community-Driven Research, Not Researcher-Imposed SolutionsLonnie Nelson's approach flips the traditional research model by centering the priorities of American Indian and Alaska Native communities. Rather than imposing outside solutions, he collaborates with community members to identify needs and co-create potential interventions, then seeks funding to rigorously test these ideas. This honors cultural wisdom and ensures research is relevant and respectful. -Reclaiming Indigenous Roots in Motivational InterviewingA fascinating point Nelson brings up is that motivational interviewing—a mainstream therapeutic technique—has roots in Indigenous traditions. He highlights that its effectiveness comes from Native practices grounded in respect, non-judgment, and relational conversation. However, much of Western healthcare training strips these origins, sometimes making the approach feel manipulative; Nelson, instead, works to restore its original, culturally-grounded intent. -The Native Concept of “Medicine” is Holistic and TransformativeIn Native cultures, “medicine” isn't just pharmaceuticals or interventions—it's anything that can transform how you feel, from the smell of your grandmother's kitchen to community rituals. Nelson stresses that when Native people say, “culture is medicine,” it's about emotional and spiritual transformation—not just physical wellness. Next Step: Visit our website, ⁠⁠⁠⁠⁠⁠⁠Healthcare for Humans⁠⁠⁠⁠⁠⁠⁠, and join our community to enjoy exclusive benefits at ⁠⁠⁠⁠⁠⁠⁠https://www.healthcareforhumans.org/support/⁠⁠⁠⁠⁠⁠⁠ Support Our Mission: Non-clinicians, explore exclusive content and contribute to our collective journey. Be an Active Participant: Go beyond listening. Shape our narrative by co-creating episodes with us. Be part of our community by visiting⁠⁠⁠⁠⁠⁠⁠ https://www.healthcareforhumans.org/support/⁠⁠⁠⁠⁠⁠⁠. Follow us on Instagram ⁠⁠⁠⁠⁠⁠⁠@healthcareforhumanspodcast⁠⁠⁠

There's a lot of talk about the Mediterranean Diet, and when you think about this way of eating, olive oil usually comes to mind. Is this just a fad, or are there some facts to back up the claims of heart health, longevity and anti-inflammatory factors when people consume olive oil?Rob and Sandra review some evidence and look at factors that may influence why olive oil has this distinctive reputation. Predimed study from the  New England Journal of Medicine:"Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts" https://pubmed.ncbi.nlm.nih.gov/29897866/Episodes mentioned include:Nutrition Nuggets 81 - How to Use Olive Oil https://youtu.be/jpzzuzGJ6doEp 172. Do Dietary Fats Affect Inflammation?https://youtu.be/OOSLRwNBPG8Ep 23. Fats, Grease and Oils - Quality over Quantity: Lubricate the Body and Skin From Within https://youtu.be/otQdbY-s_voNutrition Nuggets 21 - Butter vs Margarinehttps://youtu.be/NIT8C3gw7NAEnjoying the show? Consider leaving a 5 star review, and/or sharing this episode with your friends and family :)Sign up for our newsletter on our website for weekly updates and other fun info. You can also visit our social media pages. We're on⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, and⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Your support helps fuel the stoke and keeps the show going strong every week. Thanks!Website: www.mywifethedietitian.comEmail: mywifetherd@gmail.com

Melissa E. Middeldorp, MPH, PhD, University of Adelaide is joined by Jenelle Dziano, Centre for Heart Rhythm Disorders, The University of Adelaide and Jared Bunch, MD, FHRS, University of Utah School of Medicine, to discuss a study that investigated the relationship between atrial fibrillation (AF), brain glymphatic function, and cognitive performance. Using MRI-derived diffusion tensor imaging along the perivascular space (DTI-ALPS), the authors found that patients with AF especially those with no paroxysmal AF exhibited impaired glymphatic activity compared to healthy controls. This reduced glymphatic function was associated with poorer cognitive performance in domains like attention and executive function, and mediation analyses suggested that glymphatic dysfunction partially explains the link between AF and cognitive decline. Notably, in patients who underwent catheter ablation to restore sinus rhythm, glymphatic function significantly improved post-procedure. These findings highlight a novel mechanistic pathway beyond stroke or vascular risk by which AF may contribute to neurodegeneration, and they suggest that rhythm control could offer protective benefits for brain health. https://www.hrsonline.org/education/TheLead https://academic.oup.com/eurheartj/article/46/18/1733/8029578 Host Disclosure(s): M. Middeldorp:   Nothing to disclose. Contributor Disclosure(s): J. Dziano: Nothing to disclose. J. Bunch: Honoraria/Speaking/Consulting: Pfizer, Inc., Heart Rhythm Society

Dr Kavi (Mufti) Haji arrived in Australia with her toddler son and husband in 1995 due to the difficult situation in Iraq during the Gulf War. She and her husband had both studied medicine and worked in rural areas in Iraq. When they arrived in Melbourne they had to study and pass exams in order to continue in their fields. Dr Haji has achieved a lot since arriving here despite the obstacles she faced. Dr Haji is now a staff consultant intensivist, and supervisor of training at Peninsula Health, Mornington Peninsula Victoria, Australia. She is an academic physician and an adjunct senior lecturer at Monash University, Faculty of Medicine, Nursing and Health Sciences. She has special interest in echocardiography and ultrasound. She has a PhD on the role of examination-assisted ultrasound in the Intensive Care Unit. Her other interest is teaching. She is a faculty in various courses in critical care, including mechanical ventilation and critical care ultrasound and echocardiography locally and internationally. - Dr Kavî Muftî û malbata xwe di sala 1995 de ji ber rewşa aloz ya li Êraqê hatin Australya. Dr Kavî jineke gelekî zîreke û gelek serkeftin bi dest xistine. Ew li nexweşxaneyeke li Melbourne li beêê lênerîna giran/intensive care kar dike. Ew herweha doktoreke akademîke û mamosteyeke şûn-bilinde li Zanîngeha Monash.Wê PhD di sonerê de bi dest xistiye. Em derbarê jiyan wê ya li Australya pêre diaxafin.

Blamison are back and we have back up one this episode! We do some exploring into Cecil B. Demille's 1940 film North West Mounted Police starring Gary Cooper. Our guest Aren Bergstrom is our resident Canadian film and history buff and schools us on Louis Riel and all of the things that went into the Battle of Batoche which this film attempts to depict and fails in ways only DeMille could pull off. This is probably our most substantive episode to date so put on your thinking caps and set your gaze up North. Other things discussed: the films we have hated this year, A.I.Clip: from the tv show "Due South"Check out Aren and his brothers at 3 Brothers Film and Filmcast.

(00:00) Path to Medicine and Representation(10:45) Navigating Challenges in Pre-Med Studies(17:10) Navigating Learning Differences and Accommodations(29:09) Journey to Medical School Acceptance(35:27) Perseverance in the Journey to MedicineAt 17, Katya's life took an unexpected turn when a spark for dermatology lit up her path away from fashion. Join us as Katya shares her unique journey through the world of medicine, a path filled with challenges, self-discovery, and unyielding determination. Hear how her mother's insight into the demand for dermatologists and the experience of shadowing a physician of color solidified her commitment to a field where representation and cultural competence are crucial. Katya's story sheds light on the underrepresentation of Latino physicians in the U.S. and highlights the vital role of family and community support in overcoming self-doubt.The academic journey wasn't smooth sailing for Katya, who faced hurdles at Princeton that tested her resolve. Discover how initial setbacks and lower-than-expected grades fueled her imposter syndrome, propelling her to reevaluate her approach to premed studies. Through strategically pausing her coursework and immersing herself in diverse academic experiences abroad, Katya not only enhanced her college journey but also prepared for future medical school applications. Her candid discussion reveals the power of friendships, therapy, and core values in navigating the demanding world of premed, and serves as a guide for those facing similar battles.Listen as Katya recounts the emotionally charged process of medical school applications, drawing parallels to the unpredictability of dating. From receiving just one interview invite to the thrill of an acceptance call from Stanford on her birthday, her journey is a testament to perseverance against all odds. Katya opens up about learning differences and the significance of accommodations, breaking down the stigma and proving that success is within reach for those who seek the support they need. Her story is a beacon of hope for aspiring medical students, reinforcing that with grit and determination, even the most formidable barriers can be overcome.

On this episode, we define obsessive-compulsive disorder (OCD) and describe its clinical presentations, diagnostic criteria, and underlying pathophysiology. We evaluate current guidelines and evidence-based treatment strategies for managing OCD, including pharmacologic and non-pharmacologic interventions. We also, compare and contrast the efficacy, safety profiles, and appropriate use of selective serotonin reuptake inhibitors (SSRIs), cognitive behavioral therapy (CBT), and other emerging treatment modalities for OCD.  Dr. David Osser's psychopharmacology Algorithm Website  Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below:  www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast..  You can get a copy of HPM at the links below:  Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/  If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

Metformin for Treatment of Knee Osteoarthritis in Patients With Overweight or ObesityOnce-Weekly Semaglutide in Persons with Obesity and Knee OsteoarthritisSemaglutide or Tirzepatide and Optic Nerve and Visual Pathway Disorders in Type 2 Diabetes This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe

On this episode of DGTL Voices, Ed interviews Dr. Anderson Spickard, Dean of the Thomas F. Frist Jr. College of Medicine. They discuss Dr. Spickard's journey to becoming a physician and academic leader. The conversation delves into the importance of empathy, the effect of suffering on leadership, and the innovative approaches in medical education, including the integration of technology. Dr. Spickard shares personal stories of resilience, the impact of family, and his vision for cultivating future physician leaders.

If building and preserving wealth feels overwhelming, these insights are designed for ultra-high-net-worth families and corporate executives like you. In this episode of the Registered Investment Advisor Podcast, Seth Greene speaks with Gerasimos Efthimiatos, CEO of Chesapeake Asset Management, who shares his extensive experience in managing multi-asset portfolios for high-net-worth individuals and families. After 18 years in the hedge fund industry, Gerasimos now leads an innovative wealth management firm that focuses on both traditional securities and alternative investments. From offering customized wealth solutions for corporate executives to using strategic tax-aware investment strategies, Gerasimos and his team at Chesapeake help clients protect and grow their wealth across public and private markets.   Key Takeaways: → The importance of offering both traditional and alternative asset solutions. → Why alternative investments are crucial for ultra-high-net-worth families. → The key to differentiating a wealth management firm in a crowded market. → The rise of multi-asset portfolios and how to manage them effectively. → The role of sophisticated clients in helping shape investment offerings. Gerasimos Efthimiatos is an investor and strategist with twenty years of experience investing in both public and private companies globally. He is CAM's CEO and Managing Partner, where he oversees both direct and externally managed investments. Gerasimos has advised family offices, endowments, and foundations on asset allocation and investment selection, and has deep alternative investment domain expertise across private equity, hedge funds, and venture capital. Previously, Gerasimos held senior portfolio and risk manager roles in hedge funds, including as Partner at Habrok Capital Partners, an equity long/short fund based in London. He received a Master of Engineering from University of London's Imperial College of Science, Technology, and Medicine and an MBA from Cornell University's Johnson School of Management.   Connect With Gerasimos:   Website Learn more about your ad choices. Visit megaphone.fm/adchoices

A Rooted Approach to Modern Medicine: The Vision Forward My emerging and chronically iterating philosophy of medicine is a rising structural entity rooted between ancient healing wisdom and modern scientific insight. It is layered with root cause immunometabolomic thinking and built upon anthropological foundations. As a pediatrician, educator, and onion peeling thinker, I believe that a medical approach grounded in compassion, prevention, and the pursuit of root causes is the way forward. Medicine is not just about treating disease but about reshaping the very terrain in which illness arises. This can and must start with our women and children. At the heart of this vision is a belief in the power of systems biology and our deep interconnectedness. The human body cannot be understood or healed through isolated parts or siloed provider experiences. We must move beyond symptom suppression and toward an understanding of the why behind disease. Why does a child struggle with allergies, ADHD, or autoimmune illness? What factors in the environment, diet, stress response, or microbial ecosystem have altered their trajectory? Why are the governmental and NGO leaders not guiding us towards a benevolent goal of whole child health? These are the questions that shape and guide our practice....and a literature review. Dr. M

In this episode of the Intelligent Medicine podcast, Dr. Ronald Hoffman discusses the health benefits of Muscadine grapes with Dr. Stephen Talcott, a PhD chemist and professor of Food Chemistry at Texas A&M. The conversation delves into the unique biochemical properties of Muscadine grapes, their polyphenol content, and their potential health benefits compared to other fruits like Acai and common grapes. They also explore the bioavailability of nutrients, the role of phytoalexins, and the benefits of Muscadine grape-derived products. Dr. Talcott shares his insights on ongoing research at Wake Forest University, the advantages of Muscadine grape products for chemotherapy patients, and the benefits of using these products as natural health supplements. The episode highlights various Muscadine grape products available from Mighty Muscadine and Vinetastic, including juices, supplements, and topical applications, and offers a special discount code for listeners.

Dr. Hoffman continues his conversation with Stephen T. Talcott, Ph.D., Professor of Food Chemistry, Department of Food Science and Technology at Texas A&M University, about the powerful health benefits of the muscadine grape.

In this episode, Mason sits down with Dr. Carol Haddad to explore a topic close to the hearts of so many—how traditional medical treatments and complementary approaches can work together for deeper healing. Instead of choosing one path over the other, Dr. Carol shares how integration creates a more personalized, compassionate, and effective journey toward wellness. You'll hear real-world examples, practical strategies, and encouraging insights that remind us healing isn't just about treating the body—it's about nurturing the whole person: mind, body, and spirit. Whether you're a patient, caregiver, or simply curious about integrative approaches, this conversation offers hope, wisdom, and a refreshing perspective on what's possible when different worlds of medicine come together. By the end of this episode, you'll feel empowered with new ways to think about health, inspired by stories of resilience, and encouraged to see healing as more than a diagnosis—it's a journey.   Key Insights & Timestamps 02:15 The importance of blending science with holistic approaches 05:42 Why patients shouldn't feel forced to choose “either/or” in treatment 09:10 Dr. Carol's story of how she embraced integrative care 14:27 The role of nutrition and lifestyle in healing 18:55 How mindset and emotional health impact physical recovery 23:40 The science behind complementary therapies 28:05 Stories of patients who found strength through integrative care 33:12 How caregivers can support the journey with compassion 38:46 The future of medicine: collaboration over competition 42:19 Practical steps to begin your own integrative path About Dr. Carol Haddad Dr. Carol is a highly trained physician who bridges the gap between conventional oncology and holistic healing. With a background that includes a Medical Science degree from UNSW, a postgraduate degree in Medicine from the University of Sydney, specialty training in Radiation Oncology, and certification in Functional Medicine, she has more than a decade of experience treating patients within hospital and cancer center settings. Her journey led her beyond traditional medicine into the world of integrative oncology, where she combines evidence-based treatments with complementary therapies such as natural medicine, psycho-energetic healing, nutrition, and lifestyle interventions. This unique approach allows her to deliver truly holistic cancer care—addressing not just the disease, but the whole person. Dr. Carol believes that patients deserve a more balanced model of treatment, one that draws from the strengths of both science and spirituality to improve outcomes and quality of life. Today, she consults with patients and healthcare professionals worldwide, offering guidance on functional medicine, integrative cancer strategies, and ways to minimise side effects while maximising recovery. Her mission is to empower individuals to embrace long-term wellbeing, reduce recurrence risk, and experience healing in a more sustainable way. If you're curious about functional medicine, holistic oncology, or integrative cancer support, this episode is for you.   Resources Mentioned: Email: drcarolhaddad@gmail.com Website: www.drcarolhaddad.com

This week on Health Matters, we bust myths about seed oils and learn the difference between saturated fats and unsaturated fats. Dr. David Majure, a cardiologist at NewYork-Presbyterian and Weill Cornell Medicine, explains different types of fat and fatty acids, such as Omega-3 and Omega-6, including where they come from and what they mean for our health. He also shares the results of several studies that help get to the bottom of the benefits and risks of seed oils.___Dr. David Majure is the medical director of the Heart Transplant Service at NewYork-Presbyterian/Weill Cornell Medical Center and assistant professor of medicine at Weill Cornell Medicine. He specializes in the care of patients with heart failure, patients requiring or who have a heart transplant or ventricular assist device (LVAD), and patients with pulmonary hypertension. Dr. Majure received his medical degree from The Johns Hopkins School of Medicine as well as a Masters in Public Health from the Johns Hopkins Bloomberg School of Public Health. He completed his training in cardiology and advanced heart failure at the University of California, San Francisco, where he also served as an assistant clinical professor of medicine. He subsequently served as director of Research of the Advanced Heart Failure Program at the MedStar Washington Hospital Center in Washington, D.C and Director of Mechanical Circulatory Support at North Shore University Hospital, where he developed the left ventricular assist device (LVAD) program. He has contributed extensively to research and has served as principal investigator in multiple clinical trials, exploring all aspects of advanced heart failure. Dr. Majure has been recognized as a Castle Connolly Top Doctor since 2020.___Health Matters is your weekly dose of health and wellness information, from the leading experts. Join host Courtney Allison to get news you can use in your own life. New episodes drop each Wednesday.If you are looking for practical health tips and trustworthy information from world-class doctors and medical experts you will enjoy listening to Health Matters. Health Matters was created to share stories of science, care, and wellness that are happening every day at NewYork-Presbyterian, one of the nation's most comprehensive, integrated academic healthcare systems. In keeping with NewYork-Presbyterian's long legacy of medical breakthroughs and innovation, Health Matters features the latest news, insights, and health tips from our trusted experts; inspiring first-hand accounts from patients and caregivers; and updates on the latest research and innovations in patient care, all in collaboration with our renowned medical schools, Columbia and Weill Cornell Medicine. To learn more visit: https://healthmatters.nyp.org

For the first time since Hurricane Katrina made landfall 20 years ago, you can take a train ride across the Gulf Coast, from Mobile to New Orleans. And all these years later, the cities along that route are still living with the storm's aftermath. In this episode, we hop aboard the train and make four Gulf Coast stops along the way to share that story. About what happened during Katrina. How some places built back better, and how others are still trying to figure out how to rebuild.This episode was reported and hosted by Stephan Bisaha of the Gulf States Newsroom. Sea Change's executive producer, Carlyle Calhoun, co-hosted the episode.Sea Change is a WWNO and WRKF production. We are part of the NPR Podcast Network and distributed by PRX. For another great podcast serving up more great stories from the region, check out Gulf States Gumbo wherever you get your podcasts.Sea Change is made possible with major support from the Gulf Research Program of the National Academy of Sciences, Engineering, and Medicine. Sea Change is also supported by the Water Collaborative of Greater New Orleans. WWNO's Coastal Desk is supported by the Walton Family Foundation, the Meraux Foundation, and the Greater New Orleans Foundation. 

Ice helmet! Then, Allison and Gabe answer a listener's question about whether it would be okay to get back together with their ex while still very much needing to heal. If you get back together, what would be different this time? Then, Michigan Secretary of State Jocelyn Benson joins the show to talk about her methods for fighting back against Trump and his cronies. And finally, why won't people take a goddamn Advil? (jkjk)Check out all of our content on Patreon, Ad Free! Watch the full episodes of TLDRI, listen to the full episodes of The Variety Show, watch the International Question and Topix videos, join us for a monthly livestream, PLUS MORE:https://www.patreon.com/justbetweenusThis has been a Gallison ProductionProduced by Melisa D. Monts and Diamond MPrint ProductionsPost-Production by Coco LlorensProduction Assistance by Melanie D. WatsonOur Sponsors:* Check out Rosetta Stone and use my code TODAY for a great deal: https://www.rosettastone.comSupport this podcast at — https://redcircle.com/just-between-us/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Host Bill Reichart talks to author Dr. Ashley Tauriac about how it isn’t a choice between being an “excellent” Christian and an “excellent” physician.

In today's episode, supported by Boehringer Ingelheim, we spoke with Ticiana Leal, MD, and Misako Nagasaka, MD, PhD, about the FDA approval of zongertinib (Hernexeos) for previously treated patients with HER2 TKD–mutant advanced non–small cell lung cancer (NSCLC). Dr Leal is an associate professor and director of the Thoracic Medical Oncology Program in the Department of Hematology and Medical Oncology at Emory University School of Medicine in Atlanta, Georgia; as well as medical director of the Clinical Trials Office and leader of the Lung Cancer Disease Team at the Winship Cancer Institute of Emory University. Dr Nagasaka is an associate professor of medicine in the Division of Hematology and Oncology at the University of California, Irvine (UCI) School of Medicine; as well as a medical oncologist at UCI Health. In our conversation, Drs Leal and Nagasaka discussed the significance of this approval, key efficacy and safety findings from the pivotal phase 1 Beamion LUNG-1 trial (NCT04886804), and where zongertinib currently fits into the NSCLC treatment paradigm.

Progressive supranuclear palsy and corticobasal syndrome are closely related neurodegenerative disorders that present with progressive parkinsonism and multiple other features that overlap clinically and neuropathologically. Early recognition is critical to provide appropriate treatment and supportive care. In this episode, Teshamae Monteith, MD, FAAN speaks with Nikolaus R. McFarland, MD, PhD, FAAN, author of the article “Progressive Supranuclear Palsy and Corticobasal Syndrome” in the Continuum® August 2025 Movement Disorders issue. Dr. Monteith is the associate editor of Continuum® Audio and an associate professor of clinical neurology at the University of Miami Miller School of Medicine in Miami, Florida. Dr. McFarland is an associate professor of neurology at the University of Florida College of Medicine at the Norman Fixel Institute for Neurological Diseases in Gainesville, Florida. Additional Resources  Read the article: Progressive Supranuclear Palsy and Corticobasal Syndrome Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @headacheMD Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Monteith: Hi, this is Dr Teshamae Monteith. Today I'm interviewing Dr Nikolaus McFarland about his article on progressive supranuclear palsy and cortical basilar syndrome, which appears in the August 2025 Continuum issue on movement disorders. Welcome, how are you? Dr Farland: I'm great. Thank you for inviting me to do this. This is a great opportunity. I had fun putting this article together, and it's part of my passion. Dr Monteith: Yes, I know that. You sit on the board with me in the Florida Society of Neurology and I've seen your lectures. You're very passionate about this. And so why don't you first start off with introducing yourself, and then tell us just a little bit about what got you interested in this field. Dr Farland: I'm Dr Nicholas McFarlane. I'm an associate professor at the University of Florida, and I work at the Norman Fixel Institute for Neurological Diseases. I am a director of a number of different centers. So, I actually direct the cure PSP Center of Care and the MSA Center of Excellence at the University of Florida; I also direct the Huntington's clinic there as well. But for many years my focus has been on atypical parkinsonisms. And, you know, I've treated these patients for years, and one of my focuses is actually these patients who suffer from progressive supranuclear palsy and corticobasal syndrome. So that's kind of what this review is all about. Dr Monteith: You probably were born excited, but I want to know what got you interested in this in particular? Dr Farland: So, what got me interested in this in particular was really the disease and the challenges that's involved in it. So, Parkinson's disease is pretty common, and we see a lot of that in our clinic. Yet many times, roughly about 10 to 15% of my patients present with these atypical disorders. And they're quite fascinating. They present in different ways. They're fairly uncommon. They're complex disorders that progress fairly rapidly, and they have multiple different features. They're sort of exciting to see clinically as a neurologist. I think they're really interesting from an academic standpoint, but also in the standpoint of really trying to bring together sort of a team. We have built a multidisciplinary team here at the University of Florida to take care of these patients. They require a number of folks on that team to take care of them. And so, what's exciting, really, is the challenge of treating these patients. There are very limited numbers of therapies that are available, and the current therapies that we have often really aren't great and over time they fail. And so, part of the challenge is actually doing research. And so, there's actually a lot of new research that's been going on in this field. Recently, there's been some revisions to the clinical criteria to help diagnose these disorders. So, that's really what's exciting. The field is really moving forward fairly rapidly with a number of new diagnostics, therapeutics coming out. And hopefully we can make a real difference for these patients. And so that's what really got me into this field, the challenge of trying to treat these patients, help them, advocate for them and make them better. Dr Monteith: And so, tell me what the essential points of this article. Dr Farland: So, the essential points, really, of this article is: number one, you know, just to recognize the new clinical criteria for both PSP and corticobasal syndrome, the diagnosis for these disorders or the phenotypic spectrum has really expanded over the years. So, we now recognize many different phenotypes of these disorders, and the diagnosis has gotten fairly complicated. And so, one of the goals of this article was to review those new diagnostic criteria and the different phenotypic ways these diseases present. I wanted to discuss, also, some of the neuropathology and clinicopathological overlap that's occurred in these diseases as well as some of the new diagnostic tests that are available. That's definitely growing. Some of the new studies that are out, in terms of research and clinical trials. And then wanted to review some of the approaches for treatment for neurologists. Particularly, we're hoping that, you know, this article educates folks. If you're a general neurologist, we're hoping that recognizing these diseases early on will prompt you to refer these patients to specialty clinics or movement disorder specialists early on so they can get appropriate care, confirm your diagnosis, as well as get them involved in trials if they are available. Dr Monteith: And how has the clinical criteria for PSP and cortical basilar syndrome changed? Dr Farland: I think I already mentioned there's been an evolution of the clinical criteria for PSP. There's new diagnostic criteria that were recently published, and it recognizes the multiple clinical phenotypes and the spectrum of the disease that's out there, which is much broader than we thought about. Corticobasal clinical criteria are the Dr Armstrong criteria from 2013. They have not been updated, but they are in the works of being updated. But it does recognize the classic presentation of corticobasal syndrome, plus a frontal executive predominant and then a variant that actually overlaps with PSP. So, there's a lot more overlap in these two diseases than we originally recognized. Dr Monteith: And so, you spoke a bit about FTD spectrum. So why don't you tell us a little bit about what that is? I know you mentioned multiple phenotypes. Dr Farland: What I really want to say is that both PSP and corticobasal syndrome, they're relatively rare, and what- sort of as to common features, they both are progressive Parkinson disorders, but they have variable features. While they're commonly associated with Parkinson's, they also fit within this frontotemporal lobar spectrum, having features that overlap both clinically and neuropathologically. I just want folks to understand that overlap. One of this pathological overlap here is the predominant Tau pathology in the brain, an increasing recognology- recognition of sort of the pathological heterogeneity within these disorders. So, there's an initial description, a classic of PSP, as Richardson syndrome. But now we recognize there are lots of different features to it and there are different ways it presents, and there's definitely a lot of clinical pathological overlap. Dr Monteith: Why don't we just talk about some red flags for PSP? Dr Farland: Yeah, sure. So, some of the red flags for PSP and even corticobasal syndrome are: number one is rapid progression with early onset of falls, gait difficulty, falling typically backwards, early speech and swallow problems that are more prominent than you see in Parkinson's disease, as well as eye gaze issues. So, ocular motor features, particularly vertical gaze palsy. In particular what we talk about is the supranuclear gaze palsy, and one of the most sensitive features that we've seen with these is downgaze limitation or slowed downgaze, and eventually a full vertical gaze palsy and followed supranuclear gaze palsy. So, there's some of the red flags that we see. So, while we think about the lack of response to levodopa frequently as something that's a red flag for Parkinson's, there are many times that we see Parkinson's patients, and about a quarter of them don't really respond. There's some features that don't respond to levodopa that may not be so specific, but also can be helpful in this disease. Dr Monteith: And what about the red flags for cortical basilar syndrome? Dr Farland: So, for cortical basilar syndrome, some of the red flags again are this rapidly depressive syndrome tends to be, at least in its classical present presentation, more asymmetric in its presentation of parkinsonism, with features including things like dystonic features, okay? For limb dystonia and apraxias---so, inability to do a learned behavior. One of those red flags is a patient who comes in and says, my hand doesn't work anymore, which is something extremely uncommon that you hear in Parkinson's disease. Most of those patients will present, say, I might have a tremor, but they very rarely will tell you that I can't use my hand. So look out for that sign. Dr Monteith: And let's talk a little bit about some of the advances in the fields you mentioned, evolving biomarker and imaging capacities. So, how are these advances useful in helping us understand these conditions, especially when there's so much heterogeneity? Dr Farland: I might start by talking a little bit about some of the clinical criteria that have advanced. Why don't we start there and just discuss some of the advances? I think in PSP, I think, originally we had both probable and possible diagnoses of PSP, and the diagnostic criteria were basically focused on what was what's called “classical PSP” or “Richardson syndrome”. But now we recognize that there are multiple phenotypes. There's an overlap with Parkinsonism that's slower in progression and morphs into PSP, the classical form. There's a frontal behavioral variant where patients present with that frontal behavioral kind of thing. There's a speech-language variant that can overlap with PSP. So they have prominent speech language, potentially even apraxia speech. So, recognition of these different phenotypes is sort of a new thing in this field. There's even overlap with cortical basal syndrome and PSP, and we note that the pathology can overlap as well. So, I think that's one of the things that have changed over time. And these were- recently came out in 2017 in a new publication in the Movement Disorders Society. So, in terms of diagnostic tests as well---and there's been quite a bit of evolution---really still to date, our best diagnostic test is imaging. MRI is really one of our best tests currently. Currently blood tests, spinal fluid, there's new biomarkers in terms of skin… they're still in the research phase and not necessarily very specific yet. So, we rely heavily on imaging still; and for PSP, what we're looking for largely are changes in the brain stem, and particularly focused on the midbrain. So disproportionate midbrain atrophy compared to the pons and the rest of the midbrain is a fairly specific intensive sign for PSP. Whereas in MSA we see more of a pontine atrophy compared to the midbrain. So that can be really helpful, and there are lots of different new measurements that can be done. PET scans are also being used as well. And there are new PET markers, but they still remain kind of research-based, but are becoming more and more prevalent and may be available soon for potential use. Although there's some overlap with PET tracers with Alzheimer's disease and different Tau isoforms. So, something to be wary about, but we will be seeing some of these soon coming out as well. More kind of up-to-date things include things like the spinal fluid as well as even some of the skin biopsies. And I think we've heard some word of recent studies that have come out that potentially in the very near future we might actually have some Tau protein tests that we can look at Tau either in spinal fluid or even in a skin biopsy. But again, still remains research-based and, we still need more information as to whether these tests can be reproducible and how sensitive or specific they are. Dr Monteith: It sounds like, when really approaching these patients, still, it's a lot of back to the history, back to the clinical and some basic imaging that we should be able to identify to distinguish these types of patients, and we're not quite where we need to be yet for biomarker. Dr Farland: I totally agree with you. I think it starts, really, with the clinical exam and that's our main focus here; and understanding some of the new clinical criteria which are more sensitive, but also specific, too. And they're really useful to look at. So, I think reviewing those; patients do progress, following them over time can be really useful. And then for diagnosis, getting imaging if you suspect a patient has an atypical presentation of parkinsonism, to look for signs or features that might be specific for these different disorders. Dr Monteith: Why don't we take a typical case, a typical patient that you would see in clinic, and walk us through the thought process---especially, maybe they presented somewhat early---and the different treatment approaches to helping the patient, and of course their family. Dr Farland: Yeah, sure. So, a typical patient might be someone who comes in with, like, a three year history of progressive gait problems and falling. And let's say the patient says, I'm falling backwards frequently. They may have had, like, a rib fracture, or they hit their head once, and they're describing some speech issues as well. Now they're relying on a walker and family members saying they rarely let them be by themselves. And there may be some slowing of their cognitive function and maybe a bit of withdrawal. So that's a typical patient. So, the approach here is really, what are some of the red flags? I think already you hear a red flag of a rapidly progressive disease. So, Parkinson's disease patients rarely have frequent falls within the first five years. So, this is within three years or less. You're already hearing early onset of gait problems and falling, and particularly falling backwards rather than forwards as often Parkinson's disease patients do. You're hearing early speech problems and maybe a subtle hint of cognitive slowing and some withdrawal. So, a lot of things that sort of are red flags. So, our approach really would be examining this patient really closely. Okay? We'd be listening to the history, looking at the patient. One thing is that some of these patients come in, they may be in a wheelchair already. That's a red flag for us. If they're wearing sunglasses---sometimes we see that patients, they have photosensitivity and they're in a chair and they're wearing sunglasses---you take the glasses off and you look at their face and they have that sort of a facial stare to them---not just the masked face, but the stare---and their eyes really aren't moving. So, another kind of clue, maybe this is probably something atypical, particularly PSP is what I'm thinking about. So, the approach is really, do a thorough exam. I always recommend looking at eye movements and starting with volitional saccades, not giving them a target necessarily, but asking them to look up and then look down. And then particularly look at the speed of downgaze and whether they actually have full versions down, are able to do that. That's probably your most sensitive test for a patient who has PSP. Not the upgaze, which can be- upgaze impairment in older patients can be nonspecific. So, look for that down gaze. So, if I can get out one message, that's one thing that can be easily done and examined fairly quickly for diagnosis of these patients. And then just look for signs of rigidity, bradykinesia, maybe even some myelopraxia, and then look at their gait carefully so that there's a high suspicion. Again, if there's some atypical features, imaging is really important. So, my next step would be probably getting an MRI to evaluate whether- do they have brain somatrophy or other widespread atrophy or other signs? You need to think about your differential diagnosis for some of these patients as well. So, common things are common; vascular disease, you can't have vascular parkinsonism or even signs of NPH. Both of those can present with progressive gait difficulty and falls. So, the gait may look more like Parkinson's rather than ataxic gait that we see in classic PSP, but still they have early gait issues, and that can be a mimicker of PSP, So looking for both of those things in your imaging. Think about sort of autoimmune potentially causes. So, if they have a really rapid progressive cause, there are some rare autoimmune things. There have been recent reports of things like IgLON5, although there's limited cases, but we're doing more screening for some of those autoimmune causes. And then even some infectious causes like Whipples, that are rarely present like this. Okay? And have other signs and features. Dr Monteith: So, let's say you diagnose this patient with PSP and you're assessing the patients to see how you can improve their quality of life. So, what are some potential symptomatic managements that will help our patient? Dr Farland: I recommend for most all of these patients… while the literature indicates that many patients with PSP, and especially corticobasal syndrome, don't respond well to levodopa. So, the classic treatment for parkinsonism. However, we all recommend a trial of levodopa. These patients may respond partially to doses of levodopa, and we try to push the doses a bit higher. So, the recommended trial is usually a dose up to roughly 1000 milligrams of levodopa per day. And give it some time, at least two, if not actually three months of a trial. If not well-tolerated, you can back off. If there's no response at all or no improvement, then slowly back off and taper patients off and ask them to tell you whether they feel like they're actually worsening. So, many patients, sometimes, don't recognize the improvements, or family members don't recognize it until we actually taper them back off. And they may end up saying there are some other things that even recognize. Even some nonmotor benefits can be seen with levodopa. In some cases, we do keep them on levodopa, but levodopa's our best therapy for this. Dopamine agonists, MAO inhibitors, have all been sort of tried and they've been studied, but often don't really help or fail to help benefit these patients and could be fraught with some other side effects. I think many people do also turn to Amantadine as a treatment for Parkinson's, gait problems, freezing, if you see it in these disorders. Yet Amantadine is fraught with issues of side effects, including cognitive issues, and I think is not well-tolerated. But there are the rare patient who actually does respond to this or claims they respond to this. By and large, these patients relentlessly progress, unfortunately. So, beside treatment of other symptoms, I think it's really important to recognize that they require supportive cares and therapy. So, starting those early on and getting your allied healthcares kind of involved. So that includes people like physical, occupational therapy for the gait issues, the falls, occupational therapy for doing daily activities. Speech language pathology can be really a critical player for these because of the early speech and language issues, as well as swallow difficulties. Swallow is compared quickly in these patients. And so, we do recommend the screening evaluation, then often following patients either every six- or even annually, at least, with a swallow evaluation. And we recommend the fluoroscopic-guided kind of modified barium swallow for these patients.  Dr Monteith: And how does that differ if, let's say, the patient had cortical basilar syndrome? What are some of the symptomatic treatments that would be high on your consideration? Dr Farland: So actually, these patients also have a very similar approach, and they often have some overlapping features. Maybe a little bit of difference in terms of the level of apraxia and some dystonic features that you see in corticobasal syndrome. So, as I mentioned earlier that these patients have a more typ- when they present, typically have a more asymmetric presentation. And one of the biggest issues is this limb apraxia. They may have abnormal movements as well as, like, the alien limb-type phenomena as well. So, the focus of therapy, while similar in the sense we focus on the parkinsonism, I do always try levodopa and try to ramp up the doses to see if it benefits. It does often fail, but it's definitely worth trying. The other focus of these patients is trying to treat symptoms. Dystonia, those features… in some cases, we can help; if it's painful or uncomfortable, muscle relaxants can be used. If it's vocal, things like Botox can be really helpful. Often times it is more palliative than actually restorative in terms of function, but still can be really helpful for patients who ask about pain and discomfort and trying to treat. And then of course, again, the focus on our supportive care. We need to build that network and build that team of folks, the therapists, the physical, occupational, and the speech therapist to help them. If they have language problems---like either in PSP or corticobasal---I'll also include my request to a speech language pathologist to work on cognitive function. That's a special, additional thing you have to ask for and then specifically request when you make a referral to a speech language pathologist. Dr Monteith: That is so important. I think keeping the simulation, keeping the social support, and I would probably guess that you would also include screening for sleep and mood disorder. Dr Farland: Absolutely. Mood disorders are really big in these diseases. Patients are suffering terribly. You do hear about labile mood in both of these diseases, particularly PSP; and even what's called pseudobulbar palsy, where the mood is not always congruent with the affect. So they may laugh or cry inappropriately, and particularly the crying can be very disturbing to family and caregivers to see that. And so, treating those things can be really important. So always asking about the mood issues. Depression in particular is something that we're very sensitive about, and there is a higher incidence of suicidal ideations. Asking about that and feeling and making sure that they are in a safe environment can be really important. Dr Monteith: Thank you so much. Dr Farland: Thank you. Dr Monteith: Today I've been interviewing Dr Nikolaus McFarland about his article on progressive supranuclear palsy and cortical basilar syndrome, which appears in the August 2025 Continuum issue on movement disorders. Be sure to check out Continuum Audio episodes from this and other issues, and thank you to our listeners for joining today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

The human body is an amazing example of biological engineering, with a myriad of interconnecting systems that produce unique capabilities. We further explore this conversation on this episode.Dr. Randy Guliuzza is the president of the Institute for Creation Research. He is a leading biological design theorist and is actively expanding ICR's scientific research and heading the critical endeavor to develop a theory of biological design. He has represented ICR in several scientific debates at secular universities and in other forums. He holds a Doctor of Medicine from the University of Minnesota and a Master of Public Health from Harvard University. Dr. Guliuzza also has a B.S. in engineering from the South Dakota School of Mines and Technology and a B.A. in theology from Moody Bible Institute. He was board certified in aerospace medicine, and he is a licensed professional engineer. During his career he served as chief of aerospace medicine for the 28th Bomb Wing. Prior to that, he worked nine years in the Navy Civil Engineer Corps. Dr. Guliuzza and his wife, June, were high school sweethearts and have been married for 47 years. June and Randy have three incredible children and are proud grandparents of four girls and three boys.https://www.icr.org/We also highly encourage you when visiting the website to click on Publications and review the Acts & Facts section. It is very helpful info. Please also visit them on You tube. With over 950,000 subscribers they are providing great content. @icrscience

In this episode of the PFC Podcast, Noel discusses the complexities and challenges of maritime medicine, emphasizing the importance of training, knowledge, and operational flexibility. He shares insights from his extensive experience, highlighting the unpredictable nature of the ocean and the necessity of effective communication and integration with host nation partners. Noel advocates for a focus on practical training and the need for a forward-thinking approach to tackle operational challenges in a collaborative manner.TakeawaysCourage in the absence of fear is stupidity.Training should focus on knowledge, not just equipment.The ocean's unpredictability complicates operations.Effective communication is crucial in maritime environments.Over-planning can lead to operational failures.Training is essential for operational success.Integrating with host nation partners enhances effectiveness.Technology should be a last resort solution.Operational flexibility is key in dynamic environments.A joint effort is necessary for tackling complex challenges.Chapters00:00 Introduction and Context of the Mission02:53 Challenges in Maritime Operations05:38 Operational Planning and Flexibility08:30 Communication Strategies in Maritime Environments11:15 Training and Integration with Host Nation Partners14:12 Operational Autonomy and Cross-Training16:50 Emphasizing Training Over Technology19:25 Conclusion and Call to ActionFor more content, go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.prolongedfieldcare.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Consider supporting us: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠patreon.com/ProlongedFieldCareCollective⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.lobocoffeeco.com/product-page/prolonged-field-care⁠⁠

Medicine and Motherhood with Dr. Eliza Lo ChinThis episode of The Girl Doc Survival Guide features Dr. Eliza Lo Chin, Executive Director of the American Medical Women's Association (AMWA) and former AMWA President. Dr. Chin, an internist with a focus on women's health, shares her personal journey balancing her career, motherhood, and marriage. She discusses the inspiration behind her anthology, 'This Side of Doctoring: Reflections from Women in Medicine,' and reflects on her path to becoming the Executive Director of AMWA. The conversation touches on the challenges of achieving work-life balance, the importance of community and mentorship, and the evolving role of women in medicine. Dr. Chin emphasizes the diverse opportunities available within the medical profession and encourages female physicians to forge their unique paths.00:00 Introduction and Guest Welcome00:43 Motherhood and Medicine01:57 Inspiration Behind the Book02:58 Challenges and Historical Perspectives05:47 Path to Leadership in AMWA08:40 Reflections on Work-Life Balance10:40 Final Thoughts and Encouragement

In this week's episode of the Midwifery Wisdom Podcast, host Shiphrah Israel sits down with Zaire Sabb—Clinical Herbalist, Traditional Midwife, Registered Nurse, and founder of Mystic Momma Herbals.Zaire shares her remarkable journey from pediatric cardiac transplant nursing to apprenticing with grand midwives in Georgia and herbal masters in Nigeria, weaving together clinical knowledge, traditional midwifery, and holistic herbalism. She discusses the vital difference between community herbalists and clinical herbalists, how unresolved emotions can manifest physically in the body, and why reclaiming herbal wisdom is essential for reproductive health and sovereignty.We also dive into her new book, Herbal Harmony: A Comprehensive Guide to Using Herbs to Help with Reproductive Health, which empowers readers to better understand their bodies, advocate for themselves in medical spaces, and pass on generational wisdom to their families.✨ Topics we cover:The path from allopathic nursing to traditional midwiferyWhat sets a clinical herbalist apart from community herbalismThe role of emotions, trauma, and lifestyle in reproductive healthEveryday herbs growing in your own backyardPractical steps to begin your herbal journeyHow Herbal Harmony helps bridge the gap between patients and providers

Today, BeMo Experts explain tips on how to answer why medicine.  Like the podcast? Check out our website at BeMoAcademicConsulting.com Don't forget to subscribe to our channel and follow us on Facebook, Instagram, and Twitter for more great tips and other useful information!  YouTube: https://www.youtube.com/c/BeMoAcademicConsultingInc  Facebook: https://www.facebook.com/bemoacademicconsulting  Instagram: https://www.instagram.com/bemo_academic_consulting/  Twitter: https://twitter.com/BeMo_AC  TikTok: https://www.tiktok.com/@bemoacademicconsulting 

Welcome back to Ditch the Labcoat. Today's episode dives deep into a topic that's been quietly reshaping lives and families across the globe: gambling addiction. Host Dr. Mark Bonta sits down with Dr. Daniela Lobo, a leading expert in addiction psychiatry, to explore just how dramatically gambling—especially online and sports betting—has surged in prevalence, fueled by intensive marketing and made even more accessible by the pandemic's isolation.Together, Dr. Bonta and Dr. Lobo break down the reality behind those flashy ads and glossy casino images, peeling back the curtain on the true costs of problem gambling. They explore not just the personal financial and mental fallout, but the ripple effects that devastate families, drive up debt, worsen mental health struggles, and even intersect with substance use disorders. As gambling apps, sports betting, and even crypto-trading continue to blur the lines between entertainment and addiction, the doctors unpack why so many young adults—and increasingly, teens—find themselves hooked.Dr. Lobo shares practical insights for recognizing gambling problems, supporting loved ones, and opening honest conversations with kids. Most importantly, they question whether the billions gained in gambling revenue are truly worth the social and health costs we're only beginning to acknowledge.If you've ever wondered what really drives gambling addiction, how to spot it, or what responsible action looks like for individuals and society, you won't want to miss this eye-opening, evidence-based conversation. Let's ditch the lab coat and get real about gambling in our modern age.Episode LessonsGambling Addiction: Not a Choice — A medical disorder with devastating consequences, not a weakness or bad habit.Online Gambling's Rapid Expansion — Pandemic and marketing fueled a surge, making betting more accessible than ever.Marketing Drives Gambling Behaviors — Aggressive ads and sports integration normalize betting, increasing risks across all ages.Health Impact Beyond Money — Gambling harms mental, emotional, and even physical health, adding layers of stress.Younger Generations at Risk — Sports and digital platforms expose youth to gambling without proper safeguards.Overlap With Other Addictions — Gambling often co-occurs with mental health and substance use disorders.Paths to Treatment and Recovery — Counseling, family support, financial planning, and early intervention provide hope.Financial Ruin and Family Toll — Hidden gambling devastates households, with debt triggering further destructive cycles.Policy and Regulation Matter — Weak oversight allows profit-driven expansion while shifting costs to families.Prevention Through Education — Open dialogue and awareness reduce risks, counter marketing, and build resilience.Episode Timestamps03:21 – Addiction's Evolving Forms: Gambling Alert 07:08 – COVID-19's Impact on Gambling Behavior 11:56 – Gambling's Mental and Physical Toll 13:48 – Accessibility Fuels Gambling Issues 18:03 – Teens, Gambling, and Sports Obsession 22:25 – Problem Gambling's Significant Impact 25:36 – Gambling Disorders and Mental Health 29:18 – iGaming Self-Exclusion & Support 30:30 – Supporting Families with Addicted Loved Ones 36:00 – Modern Gambling: Signs and Challenges 39:02 – Gambling and Risk Awareness Conversation 42:33 – Understanding Moderation and Gambling Risks 45:23 – Ethics of Gambling Expansion 47:03 – Cautionary Insights on Gambling AppsDISCLAMER >>>>>>    The Ditch Lab Coat podcast serves solely for general informational purposes and does not serve as a substitute for professional medical services such as medicine or nursing. It does not establish a doctor/patient relationship, and the use of information from the podcast or linked materials is at the user's own risk. The content does not aim to replace professional medical advice, diagnosis, or treatment, and users should promptly seek guidance from healthcare professionals for any medical conditions.   >>>>>> The expressed opinions belong solely to the hosts and guests, and they do not necessarily reflect the views or opinions of the Hospitals, Clinics, Universities, or any other organization associated with the host or guests.    Disclosures: Ditch The Lab Coat podcast is produced by (Podkind.co) and is independent of Dr. Bonta's teaching and research roles at McMaster University, Temerty Faculty of Medicine and Queens University. 

How can biotech leaders navigate the complexities of neurodegenerative research while tackling today's funding challenges? In this episode, host Elaine Hamm, PhD, welcomes Vikas Sharma, PhD, Chief Business Officer at QurAlis, for an insightful conversation on innovation, leadership, and fundraising in the biotech sector. Drawing from his extensive experience with ALS and neurodegeneration research, Vikas shares lessons on balancing science with business, navigating board dynamics, and finding creative approaches to raise capital. In this episode, you'll discover: Why genetic insights are reshaping neurodegenerative research. How to creatively approach funding when investors are focused on lower-risk, later-stage opportunities. Practical strategies for balancing science, investors, and board relationships to drive biotech success. Tune in to gain actionable strategies and leadership lessons that can help you move your biotech forward with confidence. Links: Connect with Vikas Sharma, PhD, and check out QurAlis. Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine. Connect with Jason Adair, MBA, and Kevin Eggan, PhD. Connect with Ian McLachlan, BIO from the BAYOU producer. Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025. Learn more about BIO from the BAYOU - the podcast. Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

Grazia Aleppo, MD, Kasey J. Coyne, MD, and Jelena Kravarusic, MD, PhD, from the Northwestern Medicine Division of Endocrinology, join the Better Edge podcast. The trio discusses a recent clinical trial they led, published in The New England Journal of Medicine. This trial aimed to evaluate the efficacy and safety of using an automated insulin delivery system for treating patients with Type 2 diabetes, a method already well established for those with Type 1 diabetes.

Dr. Carole Keim welcomes Dr. Jason Bronstein, a pediatric pulmonologist and sleep medicine specialist at Mount Sinai Hospital in New York City, to The Baby Manual. Dr. Bronstein shares his journey from general pediatrics to specializing in childhood asthma, sleep apnea in children, and other pediatric breathing issues. He explains the types of cases referred to a pulmonologist, such as persistent chronic cough, difficulty breathing, or repeated respiratory infections. Dr. Keim and Dr. Bronstein discuss how conditions like asthma or congenital lung disorders are diagnosed, and Dr. Bronstein also highlights how environmental asthma triggers, such as smoke, mould, and allergens, can affect a child's lung health. Dr. Keim and Dr. Bronstein explore how pediatric sleep studies are used to evaluate children for obstructive sleep apnea, especially those with snoring, ADHD-like symptoms, or conditions like Down syndrome or autism. Dr. Bronstein describes what to expect during a sleep study and outlines when it's appropriate. They also cover safe and effective cough remedies for children, including honey for cough, saline nebulizers, and tips for using humidifiers without causing mould exposure. This episode is all about actionable advice for parents concerned about their child's breathing, sleep quality, or lung function. Dr. Jason Bronstein, MD:Jason Bronstein, MD, is the Medical Director of the Mount Sinai Pediatric Sleep Medicine Program and Director of the Mount Sinai Children's Integrative Sleep Center.He received his medical degree from New York University School of Medicine and he completed his Pediatrics Residency at Northwell Health, Cohen Children's Medical Center. Dr. Bronstein completed his Pediatric Pulmonology Fellowship at Nemours, Alfred I. duPont Hospital for Children. He completed fellowship in Sleep Medicine at the Children's Hospital of Philadelphia and jointly at the University of Pennsylvania.He treats sleep disorders across the age spectrum, including obstructive sleep apnea, narcolepsy, insomnia, and other pulmonary, neurologic, and behavioral conditions of sleep. He performs advanced interpretation of polysomnography and associated sleep study testing.Dr. Bronstein is dedicated to improving the diagnosis and management of sleep disorders in infants, children, and adolescents. His professional activities include clinical care, graduate medical education, and research. He also treats general respiratory disorders in children in the Division of Pediatric Pulmonology, delivers multidisciplinary care of children with complex medical disorders via various special programs, and works with the adult sleep medicine and adult sleep laboratory programs in the Department of Medicine.__ Resources discussed in this episode:The Holistic Mamas Handbook is available on AmazonThe Baby Manual is also available on Amazon__Contact Dr. Carole Keim MDlinktree | tiktok | instagramContact Dr. Jason Bronstein, MDwebsite

In this powerful episode, we sit down with Christa Black, a former Christian recording artist who toured with Michael W. Smith and the Jonas Brothers for over a decade. Christa shares her shocking journey from representing the global bride of Christ at "The Call" stadium event to losing everything in Costa Rica through plant medicine ceremonies.After years as a successful Christian author and speaker, Christa found herself drawn into the New Age world through seemingly innocent concepts like manifestation and energy healing. What began with small compromises eventually led to ayahuasca and wachuma ceremonies, where she encountered false spirits, including a being claiming to be Satan who asked her to "advocate for him before the Father."Christa reveals the sophisticated deception tactics of the enemy, how plant medicine creates spiritual "loans" that must eventually be repaid, and the legal authority given to dark entities through these practices. She explains the difference between legitimate spiritual gifts and their New Age counterfeits, and how fallen angel technology has been downloaded through indigenous plant ceremonies.Most importantly, Christa shares her dramatic rescue story - how God orchestrated her return to faith through a 16-year-old bracelet and the very songs from her wedding day. Now back in relationship with Jesus, she uses her authority from having been "in their camps" to pray for others trapped in deception.This episode serves as both a warning about the growing mainstream acceptance of psychedelics and a testimony of God's relentless pursuit of His people, no matter how far they've fallen. Learn more about your ad choices. Visit megaphone.fm/adchoices

Is methylene blue the missing link for healing “incurable” diseases? Josh Trent welcomes Dr. John Lieurance, Naturopath + Founder of MitoZen, to the Wellness + Wisdom Podcast, episode 766, to reveal a roadmap for reclaiming health when modern medicine says there's no hope, and how methylene blue can reawaken your body's light, strengthen your brain, and even shift trauma responses at the cellular level. Enjoy 10% Off MitoZen The main active component in Lumetol Blue is pharmaceutical-grade Methylene Blue, which acts as a catalyst for enhanced cellular energy production. Photo-biomodulation is the term used when light therapy is used to promote positive changes in cellular and biological function. Light therapy comes in a variety of therapeutics, such as laser, infrared lamps, red light therapy, and even just the positive effects the sunlight gives our bodies. Various substances have what's called “Photo-Activated” properties, and many of these are being looked at as therapeutics. Lumetol Blue™ Bars contain the best photoactive nutrients available for strong absorption through the stomach. 10% off with code WELLNESSFORCE In This Episode, Dr. John Lieurance Uncovers: [01:20] Can Methylene Blue Heal "Incurable" Diseases? Why methylene blue was originally used in medicine to cure malaria. How methylene blue can cure cancer and Alzheimer's. Why Big Pharma didn't manage to create a cure for Alzheimer's. Resources: Dr. John Lieurance MitoZen - 10% off with the code WELLNESSFORCE Melatonin: Miracle Molecule by Dr. John Lieurance Chase Hughes on The Joe Rogan Experience Paul Ehrlich [11:55] Death of Natural Medicine How Rockefeller used homeopathy in his personal practice. Why the Flexner report influenced the evolution of medicine. How most pharmaceuticals are based on petroleum. Why chiropractors didn't move into the pharmaceutical-based healing. How methylene blue turns on the brain. How red light therapy combined with methylene blue IV helped Covid patients. Resources: The Flexner Report Francisco Gonzalez-Lima Drink Update - Save 25% with code JOSH25 [16:50] Get Light into Your Cells Why methylene blue is blue. How we can receive photons through methylene blue. Why we can take methylene blue without sunlight or red light therapy. Resources: SaunaSpace - 10% off with code JOSH10 [19:25] How to Strengthen The Blue Spot The role of the locus coeruleus (blue spot). How the hormone norepinephrine helps us navigate stress. Why methylene blue strengthens the blue spot. How we can alter PTSD and phobias using methylene blue. Resources: The Body Keeps the Score by Bessel van der Kolk [24:50] Is Methylene Blue Toxic? How methylene blue is made from petroleum but it's not toxic. Why methylene blue elevates mood and mitochondrial capacity. Who can benefit from taking methylene blue. How 86% of methylene blue converts to white color. Resources: Methylene Blue: Magic Bullet by Dr. John Lieurance [32:00] New Biohacking Protocol Why there are no potential side effect to methylene blue. The benefits of combining red light therapy, oxygen, and methylene blue. Why most older men have a prostate issue and how it can be prevented and treated. Resources: Brian Richards [38:25] Muse Stem Cells: A Miracle in Medicine? Why most doctors don't know about Next Generation Sequences. How Muse stem cells can support multigenerational stress endurance. Why stem cells can rebuild cartilage. How Muse stem cells eradicate cancer cells. Resources: xcell.us [44:10] Melatonin for Healing Viral Infections How Covid was another Flexner moment. Why melatonin can solve viral infections. How Trump was using melatonin to heal from Covid. Why Dr. John had to censor his website. Resources: Join MitoZen Club Ben Greenfield [49:55] Ivermectin for Covid Detoxification How ivermectin detoxes the body after Covid or the vaccine. Why spike protein can trigger other diseases. How ivermectin is very effective when used inter-nasally. Why Dr. John uses ivermectin in his products. [54:45] Your New Wellness Practice The benefits of combining breathwork with the MitoZen spray. How gold, silver, and methylene blue in Blue Eyes drops can heal eye infections within a day. Dr. John's wellness practice using sun gazing, breathwork, and MitoZen products. [59:30] Your Body Needs Support How MitoZen products have helped people with mold problems. Why synthetic doesn't always mean toxic. How we have more stressors than ever before. Why we need more patience with our bodies. How even alternative medicine practitioners may not focus on the root cause and only treat the symptoms. [01:05:35] Finding Peace amidst Chaos and Suffering Why a traumatic injury during a hurricane caused him to lose his leg. How he could see the blessing in the possibility of losing everything. Why he found a sense of peace within the chaos. How Dr. John finally chose to amputate his leg after 7 months of chronic pain. Resources: Dolphin Tale (2011) 744 Debra Silverman | Your Pain Has a Pattern… and Astrology Reveals It All (This Isn't Random) [01:14:30] The Gift of Loss What Dr. John received through losing his leg. How he allowed himself to feel and express the pain of his loss. Why there's joy on the other side of pain. How mental well-being is driven by unconscious thought energies. The purpose of the limbic system. How Dr. John has been working on removing his fear of death. Leave Wellness + Wisdom a Review on Apple Podcasts All Resources From This Episode Dr. John Lieurance MitoZen - 10% off with the code WELLNESSFORCE Melatonin: Miracle Molecule by Dr. John Lieurance Chase Hughes on The Joe Rogan Experience Paul Ehrlich The Flexner Report Francisco Gonzalez-Lima Drink Update - Save 25% with code JOSH25 SaunaSpace - 10% off with code JOSH10 The Body Keeps the Score by Bessel van der Kolk Methylene Blue: Magic Bullet by Dr. John Lieurance Brian Richards xcell.us Join MitoZen Club Ben Greenfield Dolphin Tale (2011) 744 Debra Silverman | Your Pain Has a Pattern… and Astrology Reveals It All (This Isn't Random) Power Quotes From Dr. John Lieurance "Methylene blue has been shown to be neuroprotective. If you had a stroke and you're currently taking methylene blue, you wouldn't have much damage. If you had a heart attack while you're taking methylene blue, you're very much protected." — Dr. John Lieurance "Our healthcare model, because it's been so biased with the money from Big Pharma, it's gotten out of control. And this does not limit itself to pharmaceuticals. You can get functional medicine doctors that do the same thing with natural solutions, but just treating symptoms and not actually getting down to the root cause." — Dr. John Lieurance "Through methylene blue, we can feed photons into that system and actually get a boost in vitality and energy at a cellular level. It acts like a sponge to pull the photons into the mitochondria." — Dr. John Lieurance Josh's Trusted Products | Up To 40% Off Shop All Products Biohacking⁠ Korrect Life - 15% OFF WITH CODE "JOSH15" MANNA Vitality - Save 20% with code JOSH20 HigherDOSE - 15% off with the code WELLNESSANDWISDOM PLUNGE - $150 off with discount code WELLNESSFORCE SaunaSpace - 10% off with discount code JOSH10 Ultrahuman Ring Air - 10% off with code JOSH Wellness Test Kits Tiny Health Gut Tests - $20 off with discount code JOSH20 VIVOO Health Tests - Save 30% off with code JOSH SiPhox Health Blood Test - Save 15% off with code JOSH Nutrition + Gut Health Organifi - 20% off with discount code WELLNESSFORCE Paleovalley - 15% off with the link only EQUIP Foods - 20% off with the code WELLNESS20 DRY FARM WINES - Get an extra bottle of Pure Natural Wine with your order for just 1¢ Just Thrive - 20% off with the code JOSH Kreatures of Habit - Save 20% with WISDOM20 Supplements MANNA GOLD - $20 off with the code JOSHGOLD Adapt Naturals - 20% off with discount code WELLNESSFORCE MitoZen - 10% off with the code WELLNESSFORCE Activation Products - 20% off with the code JOSH20 BiOptimizers - 10% off with discount code JOSH10 Fatty15 Essential Fatty Acids Supplement - Get 15% off with code JOSH15 Sleep BiOptimizers Sleep Breakthrough - 10% off with JOSH10 Zyppah Anti-Snoring Mouthpiece - 20% off with the code JOSH MitoZen Super SandMan Ultra™ (Melatonin Liposomal)+ | 10% off with WELLNESSFORCE Luminette Light Therapy Glasses - 15% off with JOSH Cured Nutrition CBN Night Oil - 20% off with JOSH Natural Energy MTE - Save 20% with JOSH TruKava - Save 20% with code JOSH20 Drink Update - Save 25% with discount code JOSH25 EONS Mushroom Coffee - 20% off with the discount code JOSH20 EnergyBITS - 20% off with the code WELLNESSFORCE BUBS Naturals - Save 20% with JOSH20 Fitness + Physical Health Detox Dudes Online Courses - Up to $500 off with discount code JOSH Kineon - 10% off with discount code JOSH10 Create Wellness Creatine Gummies - 20% off with discount code JOSH BioPro+ by BioProtein Technology - Save $30 OFF WITH CODE JOSH Drink LMNT - Zero Sugar Hydration: Get your free LMNT Sample Pack, with any purchase Healthy Home SunHome Saunas - Save $200 with JOSH200 JASPR Air Purifier - Save 10% with code WELLNESS Zyppah Anti-Snoring Mouthpiece - 20% off with the code JOSH Holy Hydrogen - $100 off with discount code JOSH SimplyO3 - 10% off with discount code JOSH10 LEELA Quantum Upgrade + Frequency Bundles - Get 15 days free with code JOSH15 TrulyFree Toxic- Free Cleaning Products - Get 40% off + Freebies with code WELLNESSFORCE Mental Health + Stress Release Mendi.io - 20% off with the code JOSH20 NOOTOPIA - 10% off with the discount code JOSH10 CalmiGo - $30 off the device with discount code JOSH30 QUALIA - 15% off with WELLNESSFORCE Personal Care⁠ The Wellness Company's Emergency Health Kits + More - Save 10% with code JOSH Farrow Life - Save 20% with JOSH Timeline Nutrition - 10% off with JOSH ⁠⁠Intelligence of Nature - 15% off Skin Support with the code JOSH15⁠⁠ Young Goose - Save 10% with code JOSH10 Mindfulness + Meditation BREATHE - 33% off with the code PODCAST33 Neuvana - 15% off with the code WELLNESSFORCE Essential Oil Wizardry - 10% off with the code WELLNESSFORCE Four Visions - Save 15% with code JOSH15 Lotuswei - 10% off with JOSH Clothing Rhizal Grounded Barefoot Shoes - Save 10% with code WELLNESS Earth Runners Shoes - 10% off with the code JOSHT10 Free Resources M21 Wellness Guide - Free 3-Week Breathwork Program with Josh Trent Join The Liberated Life Tribe About Dr. John Lieurance Naturopath and Chiropractic Neurologist, Dr. John Lieurance, has been in private practice for over 27 Years. Currently, with Advanced Rejuvenation, a Multi-Disciplinary Clinic, with a focus on Alternative and Regenerative Medicine, Naturopathic Medicine, Chiropractic Functional Neurology, Functional Cranial Release (FCR), Lumomed, Lyme Disease, Mold Illness, and many other Neurological Conditions. His treatments have been proven very successful in treating many chronic neurological and chronic infection conditions. He believes that toxins and infections are at the root of many conditions, including Autoimmune, Parkinson's, Alzheimer's, Inner Ear Conditions, and most Degenerative Neurologic Conditions. Website Facebook Instagram Twitter YouTube

For kids with eczema the discomfort of dry patches, constant itching and sleepless nights, can be relentless. For their parents, the search for answers is as well. In this episode, we're scratching beneath the surface of one of the most common skin conditions in pediatrics. We'll explore how to spot triggers, calm flare-ups, choose the right treatments and know when it's time to call in a dermatologist. Whether it's helping a toddler stop scratching or giving a teen the confidence to ditch the long sleeves, we're here to equip pediatricians with the tools to help their patients find relief and reclaim their skin. For this episode, we are joined by Emily Gurnee, MD. She is a Dermatologist at Children's Hospital Colorado as well as an Assistant Professor at the University of Colorado School of Medicine.  Some highlights from this episode include:  The most up-to-date information with eczema  Medication versus other remedies   How to provide care that fits into a family's routine Best ways PCPs can support kids with eczema   For more information on Children's Colorado, visit: childrenscolorado.org. 

In this inspiring episode of American Potential, host David From speaks with Dr. Chaminie Wheeler, a pediatrician who walked away from the traditional hospital system to launch a direct primary care (DPC) practice—putting patients, not paperwork, at the center of healthcare. Raised in a small village in Sri Lanka, Dr. Wheeler's passion for helping others began at a young age and followed her to Pennsylvania, where she built CCC Health from the ground up with help from the Tax Cuts and Jobs Act. She shares how the broken insurance-based model shackled her ability to treat patients with compassion and clarity. From unnecessary CT scans to delayed diagnoses, Dr. Wheeler reveals how bureaucracy often prevents real healing—and why DPC offers a better way forward. This episode dives deep into the challenges independent doctors face, the critical role of expanded Health Savings Accounts (HSAs), and how innovation thrives when government steps back. Dr. Wheeler's story is a reminder that when we trust doctors and empower patients, we unlock the real potential of American healthcare.